Literature DB >> 10500878

Cyproterone acetate treatment of Tourette's syndrome.

M Izmir, S M Dursun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10500878

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  4 in total

1.  Effects of endocrine disruptors on prosobranch snails (Mollusca: Gastropoda) in the laboratory. Part III: Cyproterone acetate and vinclozolin as antiandrogens.

Authors:  M Tillmann; U Schulte-Oehlmann; M Duft; B Markert; J Oehlmann
Journal:  Ecotoxicology       Date:  2001-12       Impact factor: 2.823

Review 2.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 3.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Tourette's Syndrome in Children.

Authors:  James E. Swain; James F. Leckman
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.